Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Shinjo

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Diabetes|May 16, 2020
Exercise-Induced Increases in Insulin Sensitivity After Bariatric Surgery Are Mediated By Muscle Extracellular Matrix RemodelingWagner S Dantas, Hamilton Roschel, Igor H Murai, et al.
Diabetes|May 12, 2021
Erratum. Exercise-Induced Increases in Insulin Sensitivity After Bariatric Surgery Are Mediated By Muscle Extracellular Matrix Remodeling. Diabetes 2020;69:1675-1691Wagner S Dantas, Hamilton Roschel, Igor H Murai, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 4, 2025
Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases: Launching a Randomized Phase 4 StudyLeonard V K Kupa, Ana Cristina Medeiros-Ribeiro, Nádia E Aikawa, et al.
Arthritis and Rheumatism|February 5, 2010
Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohortSamuel K Shinjo, Eloísa Bonfá, Daniel Wojdyla, et al.
Rheumatology (Oxford, England)|October 19, 2021
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2Samuel K Shinjo, Fernando H C de Souza, Isabela B P Borges, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 10, 2022
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patientsBruno Gualano, Carla G S Saad, Sofia M Sieczkowska, et al.
Rheumatology (Oxford, England)|May 31, 2022
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccineNadia E Aikawa, Leonard V K Kupa, Clovis A Silva, et al.
The Lancet. Rheumatology|December 13, 2021
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective studyNadia E Aikawa, Leonard V K Kupa, Sandra G Pasoto, et al.
Nature Medicine|July 31, 2021
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trialAna C Medeiros-Ribeiro, Nadia E Aikawa, Carla G S Saad, et al.
Annals of the Rheumatic Diseases|May 5, 2011
Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseasesCarla G S Saad, Eduardo F Borba, Nadia E Aikawa, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Diabetes|May 16, 2020
Exercise-Induced Increases in Insulin Sensitivity After Bariatric Surgery Are Mediated By Muscle Extracellular Matrix RemodelingWagner S Dantas, Hamilton Roschel, Igor H Murai, et al.
Diabetes|May 12, 2021
Erratum. Exercise-Induced Increases in Insulin Sensitivity After Bariatric Surgery Are Mediated By Muscle Extracellular Matrix Remodeling. Diabetes 2020;69:1675-1691Wagner S Dantas, Hamilton Roschel, Igor H Murai, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 4, 2025
Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases: Launching a Randomized Phase 4 StudyLeonard V K Kupa, Ana Cristina Medeiros-Ribeiro, Nádia E Aikawa, et al.
Arthritis and Rheumatism|February 5, 2010
Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohortSamuel K Shinjo, Eloísa Bonfá, Daniel Wojdyla, et al.
Rheumatology (Oxford, England)|October 19, 2021
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2Samuel K Shinjo, Fernando H C de Souza, Isabela B P Borges, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 10, 2022
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patientsBruno Gualano, Carla G S Saad, Sofia M Sieczkowska, et al.
Rheumatology (Oxford, England)|May 31, 2022
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccineNadia E Aikawa, Leonard V K Kupa, Clovis A Silva, et al.
The Lancet. Rheumatology|December 13, 2021
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective studyNadia E Aikawa, Leonard V K Kupa, Sandra G Pasoto, et al.
Nature Medicine|July 31, 2021
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trialAna C Medeiros-Ribeiro, Nadia E Aikawa, Carla G S Saad, et al.
Annals of the Rheumatic Diseases|May 5, 2011
Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseasesCarla G S Saad, Eduardo F Borba, Nadia E Aikawa, et al.
Pageof 16